Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A digital microfluidic platform for cell-based non-invasive testing.

iScience·2026
Same author

DROP-LCMS for wastewater surveillance of viral disease.

Lab on a chip·2026
Same author

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

Nature communications·2026
Same author

The molecular glue CLEO4-88 inhibits the ACAA1 thiolase by induced binding to GID4.

Nature chemical biology·2026
Same author

μPharma: A microfluidic, AI-driven pharmacotyping platform for single-cell drug sensitivity prediction in leukemia.

Med (New York, N.Y.)·2026
Same author

Evaluating rapid evaporative ionization mass spectrometry profiles of human breast cancer cells using a 3D in vitro assay.

Analytical and bioanalytical chemistry·2025

Related Experiment Video

Updated: Apr 26, 2026

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
08:58

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood

Published on: April 16, 2016

9.8K

Digital microfluidic platform for human plasma protein depletion.

Ningsi Mei1, Brendon Seale, Alphonsus H C Ng

  • 1Department of Chemistry, Queen's University , 90 Bader Lane, Kingston, Ontario K7L 3N6, Canada.

Analytical Chemistry
|July 25, 2014
PubMed
Summary

This study introduces a rapid, automated method using digital microfluidics and magnetic beads to efficiently remove abundant proteins like human serum albumin (HSA) and immunoglobulins (IgGs) from serum samples. This technique enhances biomarker identification by improving signal-to-noise ratios in proteomic analysis.

More Related Videos

Digital Microfluidics for Automated Proteomic Processing
10:55

Digital Microfluidics for Automated Proteomic Processing

Published on: November 6, 2009

12.2K
Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum
09:22

Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum

Published on: April 13, 2018

16.4K

Related Experiment Videos

Last Updated: Apr 26, 2026

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
08:58

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood

Published on: April 16, 2016

9.8K
Digital Microfluidics for Automated Proteomic Processing
10:55

Digital Microfluidics for Automated Proteomic Processing

Published on: November 6, 2009

12.2K
Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum
09:22

Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum

Published on: April 13, 2018

16.4K

Area of Science:

  • Biochemistry
  • Proteomics
  • Analytical Chemistry

Background:

  • Low-abundance disease biomarkers in human serum are often obscured by highly abundant proteins like human serum albumin (HSA) and immunoglobulins (IgGs).
  • Conventional methods for depleting these abundant proteins are slow, cause sample dilution, and typically cannot process multiple samples concurrently.

Purpose of the Study:

  • To develop a rapid, automated, and simultaneous method for depleting HSA and IgGs from human serum.
  • To improve the detection sensitivity of low-abundance biomarkers in proteomic analyses.

Main Methods:

  • Utilized superparamagnetic beads coated with anti-HSA, Protein A, and Protein G.
  • Employed digital microfluidics (DMF) for precise manipulation of the magnetic beads and serum samples.
  • Processed four serum samples simultaneously for efficient protein depletion.

Main Results:

  • Achieved up to 95% depletion efficiency for HSA and IgGs within 10 minutes.
  • Demonstrated an approximately 4-fold increase in the signal-to-noise ratio for detecting the low-abundance protein hemopexin using MALDI-MS.
  • Enabled simultaneous processing of multiple samples, reducing overall analysis time.

Conclusions:

  • The developed DMF-based magnetic bead method offers a fast and efficient approach for abundant protein depletion in serum.
  • This technique significantly enhances the detection of low-abundance biomarkers, holding promise for improved disease diagnosis.
  • The automation and multiplexing capabilities of this method represent a substantial advancement in proteomic sample preparation for biomarker discovery.